Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunovant Inc. logo

Director Susman Robert Graham sold $67,979 worth of shares (2,502 units at $27.17) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 36,394 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.) and more on Quantisnow.